Roche Diagnostics

Type: Company
Name: Roche Diagnostics
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Roche Diagnostics Operations Assigned Patent for Skin Securable Drug Delivery Device

By Targeted News ServiceALEXANDRIA, Va., April 22 Roche Diagnostics Operations, Indianapolis, has been assigned a patent (8,696,629) developed by three co-inventors for a "skin securable drug delivery device with a shock absorbing protective shield." ... [Published Pharmacy Choice - 11 hours ago]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Roche Ups Its Ante in Molecular POC Testing

Last week, Roche Diagnostics (Indianapolis) announced its acquisition of IQuum Inc. (Marlborough, MA), a privately held company that develops point-of-care (POC) test systems for the molecular diagnostics market. Under the terms of the deal, Roche will ... [Published Medical Design Technology - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 2 reports

Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 - New Report by MarketsandMarkets

The global Point-Of-Care Diagnostics market is broadly categorized into infectious diseases testing kits, glucose monitoring kits, coagulation monitoring kits, urinalysis testing kits, hematology testing kits, cholesterol test strips, drugs of abuse testing ... [Published Virtual Strategy Magazine - Apr 21 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Inside INdiana Business

Self-driving tech could 'transform' businessA University of Notre Dame professor says the emerging technology of driverless vehicles can "transform the landscape" of logistics. Don Howard, who leads the Riley Center for Science, Technology and Values, ... [Published NWI Times - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Patent Issued for Method for Measuring Analyte Concentration in a Liquid Sample

By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventor Lica, Georgeta ( Indianapolis, IN ), filed on December 30, 2009 , was published online on April 8, 2014 , according to news reporting originating from Alexandria, Virginia ... [Published 4 Traders - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Reports from Department of Clinical Research Highlight Recent Findings in Craniocerebral Trauma

By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Nervous System Diseases and Conditions have been published. According to news reporting from Paris, France , by NewsRx journalists, research stated, "S100B protein ... [Published 4 Traders - Apr 16 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 1 reports

Chugai Pharmaceutical files new drug application for melanoma drug

Chugai Pharmaceutical Co., Ltd. has filed a new drug application with the Ministry of Health, Labour and Welfare, or MHLW, for oral, selective BRAF kinase inhibitor vemurafenib indicated for the treatment of melanoma with BRAFV600 mutation. Also, Roche ... [Published Individual.com - Apr 14 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

HPV testing market dominated by bioMérieux SA.,Hologic Inc., Roche Diagnostics Ltd., and Qiagen N.V.

- Global HPV Testing Market 2014-2018 - a new market research report on companiesandmarkets.comVendors in the market have been focusing on mergers and acquisitions to increase their global presence and product portfolio, and to avoid loss of patent protection. ... [Published PR inside - Apr 11 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Chugai files NDA for vemurafenib for melanoma

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519), which is majority-owned by Swiss drug major Roche (ROG: SIX), has filed a new drug application to the Ministry of Health, Labor and Welfare (MHLW) for oral, selective BRAF kinase inhibitor vemurafenib ... [Published Pharma Letter - Apr 11 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Researchers develop novel molecular blood group typing technique

PUBLIC RELEASE DATE: 10-Apr-2014Philadelphia, PA, April 10, 2014 – Scientists in France have designed a new system for molecular blood group typing that offers blood banks the possibility of extensive screening of blood donors at a relatively low cost. ... [Published EurekAlert! - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Point-of-Care Diagnostic Market (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers) Worth $27.5 Billion by 2018

Dallas, TX -- ( SBWIRE ) -- 04/09/2014 -- The report “Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription ... [Published SBWire - Apr 09 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 3 reports

Roche Buys Molecular Diagnostics Company for up to $ 450m

Roche announced today that it would buy the US-based molecular diagnostics company IQuum. The Swiss Medtech giant will pay up to $ 450m in the course of the acquisition. The shareholders of IQuum will receive $275 million upfront and up to $175 million ... [Published European Medical Device Technology - Apr 07 2014]

Quotes

"In yet another embodiment of the invention, a method for inserting a subcutaneously insertable element within a subcutaneous tissue of a patient using an insertion device according to any of the preceding embodiments is provided, where the method includes inserting the penetrating member and the subcutaneously insertable element into the body and removing the penetrating member by gripping the grip portion thereof while retaining the subcutaneously insertable element in the body and further retaining the well sealing cap at an upper opening of the well."

More Content

All (187) | News (175) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (6) | Press Releases (1)
sort by: Date | Relevance
Patent Issued for Insertion Device and Method f... [Published 4 Traders - 2 hours ago]
Vermillion Appoints Chairman of Board James LaF... [Published 4 Traders - 5 hours ago]
"System and Method for Assessing Risk Associate... [Published 4 Traders - 8 hours ago]
Patent Issued for Skin Securable Drug Delivery ... [Published 4 Traders - 8 hours ago]
Roche Diagnostics Operations Assigned Patent fo... [Published Pharmacy Choice - 11 hours ago]
Misadventure ruling in case of liposuction death [Published Singapore Law Watch - 21 hours ago]
Shija Hospitals reaches another milestone NAT ... [Published E Pao - 21 hours ago]
Use of SFRP-3 in the assessment of heart failure [Published PharmCast - Apr 23 2014]
Antimicrobial and Immunomodulatory Activities o... [Published PLoS medicine - Apr 23 2014]
America's Health Insurance Plans (AHIP) Joins t... [Published BioPortfolio - Apr 22 2014]
The Personal Connected Health Alliance Launches... [Published 4 Traders - Apr 22 2014]
Hemoglobin A1C monitoring market forecast to re... [Published PR inside - Apr 22 2014]
Grand View Research: Asia Pacific PoC Diagnosti... [Published BusinessWeek - Apr 22 2014]
BUENA VISTA REGIONAL MEDICAL CENTER [Published Storm Lake Pilot Tribune - Apr 22 2014]
Roche Ups Its Ante in Molecular POC Testing [Published Medical Design Technology - Apr 21 2014]
PEG-IFN Alpha but Not Ribavirin Alters NK Cell ... [Published PLoS medicine - Apr 21 2014]
Roche’s diabetes biz bounces back—for now [Published Indianapolis Business Journal - Apr 21 2014]
World Tissue Diagnostics Market to Post 6.97% C... [Published Virtual Strategy Magazine - Apr 21 2014]
World Tissue Diagnostics Market to Post 6.97% C... [Published PRWeb - Apr 21 2014]
With IQuum Deal, Roche Gets Turnkey Entry Into ... [Published PRWeb - Apr 21 2014]
Point-Of-Care Diagnostic Market Worth $27.5 Bil... [Published Virtual Strategy Magazine - Apr 21 2014]
Point-Of-Care Diagnostic Market Worth $27.5 Bil... [Published PRWeb - Apr 21 2014]
Inside INdiana Business [Published NWI Times - Apr 18 2014]
Capsaicin Treatment Attenuates Cholangiocarcino... [Published PLoS medicine - Apr 18 2014]
Polymerase I and Transcript Release Factor Acts... [Published PLoS medicine - Apr 18 2014]
Point-Of-Care Diagnostic Market by Products, En... [Published ADVFN India - Apr 17 2014]
Study compares long-term effectiveness of diabe... [Published WUSTL Medicine & Healthcare News - Apr 17 2014]
Keynotes Named For Women's Event [Published Inside INdiana Business - Apr 17 2014]
Fluorescent Immunoassay Market worth $19.1 Bill... [Published PitchEngine - Apr 17 2014]
Peginterferon Boosts Hep B Treatment Response t... [Published American Journal of Public Health - Apr 17 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Study compares long-term effectiveness of diabe... [Published WUSTL Medicine & Healthcare News - Apr 17 2014]
Robert Boston In a five-year study, researchers are comparing long-term benefits and risks of four widely used diabetes drugs that will be given in combination with metformin (Gulcophage®), the most commonly prescribed medication for treating type 2 ...
Researchers Develop Novel Molecular Blood Group... [Published theCSRfeed - Apr 10 2014]
New Technology Can Reduce Adverse Reactions and Decrease Blood Bank Costs, Report Investigators in The Journal of Molecular Diagnostics SOURCE: Elsevier DESCRIPTION: Philadelphia, PA, April 10, 2014 /3BL Media/ – Scientists in France have designed ...
NAFA Announces Finalists for 2014 Fleet Excelle... [Published PR.com Press Releases - Mar 30 2014]
Princeton, NJ, March 30, 2014 --( PR.com )-- NAFA Fleet Management Association proudly announced the finalists for NAFA's 2014 Fleet Excellence Awards on Thursday, March 27. The Fleet Excellence Awards (or FLEXY for short) shine a spotlight on those ...
Carlyle names new chairman and CEO for OCD [Published PE Hub Blog - Feb 27 2014]
Carlyle said Thursday that it has named Dr. Martin D. Madaus to become chairman and CEO of Ortho-Clinical Diagnostics . The appointment will become effective following the closing of Carlyle’s acquisition of OCD from Johnson & Johnson , which is ...
ALEC crawls from under rock to do damage control [Published Daily Kos - Dec 03 2013]
The villains of state-level policy over at the American Legislative Exchange Council (ALEC) have run into serious trouble over the past couple years, losing enough members to create a budget shortfall and have them launching a "Prodigal Son Project" ...
1

Press Releases

sort by: Date | Relevance
OraSure Technologies Terminates Oral Fluid Drug... [Published GlobeNewswire: Acquisitions News - Nov 21 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.